期刊文献+

免疫机制在药物性肝损伤中的作用研究进展 被引量:7

下载PDF
导出
摘要 药物性肝损伤是指在药物的正常使用中,由于药物或其代谢产物所引起的肝脏损伤,以及过敏反应所致的医源性疾病,其后果包括肝脏血管损害,诱导肝硬化以及肝癌等[1]。在免疫学方面可将药物性肝损伤分为免疫介导肝损伤和非免疫损伤,非免疫损伤是药物或其代谢产物对肝细胞造成的损伤。
出处 《实用医学杂志》 CAS 北大核心 2012年第5期852-853,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献21

  • 1Deng X,Luyendyk J P,Ganey P E,et al.Inflammatory stress andidiosyncratic hepatoxicity:hints fromanimal models[J].Pharmacol Rev,2009,61(3):262-282.
  • 2王剑,刘殿武,詹思延.药物性肝病发生的机制与易感性[J].现代预防医学,2010,37(8):1600-1600. 被引量:9
  • 3Wong J,Johnston B,Lee S S,et al.A minimal role for selectins in therecruitment of leukocyte into theinflamed liver microvasculature[J].JClinical Investigat,1997,99(11):2782-2790.
  • 4Lalor P F,Edwards S,McNab G,etal.Vascular adhesion protein-1mediates adhesion and transmigrationof lymphocytes on human hepaticendothelial cells[J].J Immunol,2002,169(2):983-992.
  • 5Lalor P F,Sun P J,Weston C J,etal.Activation of vascular adhesionprotein-1on liver endothelium resultsin an NF-βdependent increase inlymphocyte adhesion[J].Hepatology,2007,45(2):465-474.
  • 6Cheng L,You Q,Yin H,et al.Involvement of natural killer T cells inhalothane-induced liver injury in mice[J].Biochem Pharmcol,2010,80(2):255-261.
  • 7Romagnani S,Maggi E,Liotta F,etal.Properities and origin of humanTh17cells[J].Mol Immunol,2009,47(1):3-7.
  • 8Kobayashi E,Kobayashi M,Tsuneyama K,et al.Halothane-induced liver injury is mediated byinterleukin-17in mice[J].ToxicolSci,2009,111(2):302-310.
  • 9Wondimu Z,Santodomingo-Garzon T,Le T,et al.Protective role ofinterleukin-17in murine NKT cell-driven acute experimental hepatitis[J].Am J Pathol,2010,177(5):2334-2346.
  • 10Holt M P,Cheng L,Ju C.Identificationand characterization of infiltratingmacrophages in acetaminophen-inducedliver injury[J].J Leukoc Biol,2008,84(6):1410-1421.

二级参考文献10

  • 1Haramburu, Pouyanne P, Imbs JI, et al. Incidence and prevalence of adverse drug reactions [J]. Presse Med, 2000, 29 (2) : 111-114.
  • 2Juntti-Patinen L, Neuvonen PJ. Durg-related deaths in a university central hospital [J]. Eur J Clin Pharmacol, 2002, 58 (7): 479-482.
  • 3Lazarou J, Pomeranz BH, Corey PN. Incidence of ADR in Hostipalized Patients [J]. JAMA, 1998, 279: 1200.
  • 4Grunhage F, Fischer HP, Sauerbruch T, et al. D.rug and toxininduced hepatotoxicity [J]. Z Gastroenterol, 2003, 41 (6) : 565- 578.
  • 5Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study [J]. Hepatology, 2002, 36: 451-455.
  • 6Meier Y, Cavallaro M, Roos M, et al. Incidence of drug-induced liver injury in medical inpatients [J]. Eur J Clin Pharmacol, 2005, 61 (2): 135-143.
  • 7Hussaini SH, O'Brien CS, Despott EJ, et al. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England [J]. EurJ Gastroenterol Hepatol, 2007, 19 (1): 15-20.
  • 8Biour M, Jaillon P.Drug-induced hepatic diseases [J]. Pathol Biol (Paris), 1999, 47 (9): 928-937.
  • 9陈世耀,蒋晓渠,刘天舒,王吉耀.药物性肝病的病因和临床表现[J].中华肝脏病杂志,2000,8(4):244-244. 被引量:88
  • 10殷新光,姒健敏,杨志宏,顾金森,潘学仙,沈道德.药源性肝病临床流行病学分析[J].中华流行病学杂志,2004,25(4):364-364. 被引量:27

共引文献8

同被引文献99

引证文献7

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部